Mercer Global Advisors
MEDS

Mercer Global Advisors’s DataMeds AI, Inc. Common Stock MEDS Stock Holding History

Mercer Global Advisors’s Portfolio MEDS Stock Details MEDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$62 Buy
+20
New +$98 ﹤0.01% 5996

Other funds holding MEDS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
DB
Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Mercer Global Advisors's MEDS Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in DataMeds AI, Inc. Common Stock (MEDS) in Q2 2026: 20 shares worth $62. The stake represents ﹤0.01% of the portfolio and ranks #5996 among its holdings.

6 funds tracked by Wall St. Rank hold MEDS as of Q2 2026.

  • Mercer Global Advisors held 20 shares of DataMeds AI, Inc. Common Stock worth $62 as of Q2 2026.
  • DataMeds AI, Inc. Common Stock was a new Mercer Global Advisors position in Q2 2026.
  • DataMeds AI, Inc. Common Stock made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5996 holding.
  • 6 funds tracked by Wall St. Rank held DataMeds AI, Inc. Common Stock as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.